Capital International Investors
Source: SEC Form 13F · as of Mar 2026Capital International Investors holds 20 biotech & pharma companies tracked by BioSniper, totaling $16.43B in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$16.43B
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 6,116,692 | $5.62B |
| ABBVAbbVie Inc. | 14,418,993 | $3.13B |
| AMGNAMGEN INC | 7,122,275 | $2.51B |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,001,312 | $2.43B |
| JNJJOHNSON & JOHNSON | 2,617,363 | $639.8M |
| BMYBRISTOL MYERS SQUIBB CO | 8,432,445 | $511.2M |
| GHGuardant Health Inc. | 3,481,318 | $321.6M |
| ELVElevance Health Inc. | 1,050,861 | $307.6M |
| MCKMcKesson Corporation | 309,815 | $268.1M |
| MRKMerck & Co., Inc. | 870,261 | $104.7M |
| QGENQIAGEN N.V. | 2,436,169 | $97.5M |
| CYTKCYTOKINETICS INC | 1,338,803 | $88.2M |
| SYRESpyre Therapeutics, Inc. | 1,746,129 | $88.1M |
| TEVATeva Pharmaceutical Industries Limited | 2,823,274 | $85.0M |
| TERNTerns Pharmaceuticals, Inc. | 1,424,504 | $75.1M |
| CRSPCRISPR Therapeutics AG | 1,186,794 | $56.5M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 1,441,131 | $46.1M |
| CAHCardinal Health Inc. | 128,889 | $27.2M |
| LEGNLegend Biotech Corp | 647,850 | $11.7M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 48,616 | $1.6M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.